1. Stocks
  2. Celldex Therapeutics Inc.
  3. Swot
swot-logo

Celldex Therapeutics Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Celldex Therapeutics Inc. has 3 Strengths, 17 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

PEG lower than Industry PEG

Company with Low Debt

Stock with Low PE (PE < = 10)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Highest fall from 52 Week High

Top Losers

Near 52 Week Low

Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Weak Momentum: Price below Short, Medium and Long Term Averages

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Declining profits every quarter for the past 3 quarters

RSI indicating price weakness

Near 52 Week Low

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month